These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35439287)

  • 1. Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis.
    Gooptu M; Kim HT; Jacobsen E; Fisher DC; LaCasce A; Ho VT; Cutler CS; Koreth J; Soiffer RJ; Antin JH; Berliner N; Nikiforow S
    Blood Adv; 2023 Jun; 7(11):2309-2316. PubMed ID: 35439287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.
    Marsh RA; Kim MO; Liu C; Bellman D; Hart L; Grimley M; Kumar A; Jodele S; Myers KC; Chandra S; Leemhuis T; Mehta PA; Bleesing JJ; Davies SM; Jordan MB; Filipovich AH
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1625-31. PubMed ID: 24035782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Nationwide Retrospective Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Adult Hemophagocytic Lymphohistiocytosis.
    Kim H; Mizuno K; Masuda K; Sakurai M; Ara T; Naito K; Uehara Y; Yamamoto G; Osada M; Machida S; Horio T; Fukushima K; Mori Y; Ichinohe T; Fukuda T; Atsuta Y; Kataoka K
    Transplant Cell Ther; 2024 Apr; 30(4):419.e1-419.e12. PubMed ID: 38266963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age Impacts Risk of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Non-Severe Combined Immune Deficiency Inborn Errors of Immunity.
    Fitch T; Lane A; McDonnell J; Bleesing J; Jordan M; Kumar A; Khandelwal P; Khoury R; Marsh R; Chandra S
    Transplant Cell Ther; 2024 Jan; 30(1):101.e1-101.e12. PubMed ID: 37821080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.
    Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1722-1728. PubMed ID: 28647558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Outcomes of Central Nervous System Hemophagocytic Lymphohistiocytosis Relapse after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation.
    Lounder DT; Khandelwal P; Chandra S; Jordan MB; Kumar AR; Grimley MS; Davies SM; Bleesing JJ; Marsh RA
    Biol Blood Marrow Transplant; 2017 May; 23(5):857-860. PubMed ID: 28219834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in primary hemophagocytic lymphohistiocytosis.
    Hamidieh AA; Pourpak Z; Hashemi S; Yari K; Fazlollahi MR; Movahedi M; Behfar M; Moin M; Ghavamzadeh A
    Eur J Haematol; 2014 Apr; 92(4):331-6. PubMed ID: 24330187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.
    Allen CE; Marsh R; Dawson P; Bollard CM; Shenoy S; Roehrs P; Hanna R; Burroughs L; Kean L; Talano JA; Schultz KR; Pai SY; Baker KS; Andolina JR; Stenger EO; Connelly J; Ramirez A; Bryant C; Eapen M; Pulsipher MA
    Blood; 2018 Sep; 132(13):1438-1451. PubMed ID: 29997222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein deficiency/X-linked lymphoproliferative disease type 1.
    Marsh RA; Bleesing JJ; Chandrakasan S; Jordan MB; Davies SM; Filipovich AH
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1641-5. PubMed ID: 24923536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation.
    Marsh RA; Vaughn G; Kim MO; Li D; Jodele S; Joshi S; Mehta PA; Davies SM; Jordan MB; Bleesing JJ; Filipovich AH
    Blood; 2010 Dec; 116(26):5824-31. PubMed ID: 20855862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical characteristics of adult hemophagocytic lymphohistiocytosis treated with haploidentical donor hematopoietic stem cell transplantation].
    Fu L; Wei N; Wang JS; Wu L; Wang YN; Huang DY; Liu JL; Wang Z
    Zhonghua Nei Ke Za Zhi; 2017 Apr; 56(4):273-278. PubMed ID: 28355720
    [No Abstract]   [Full Text] [Related]  

  • 12. The Role of Hematopoietic Stem Cell Transplantation in Treatment of Hemophagocytic Lymphohistiocytosis.
    Nikiforow S
    Hematol Oncol Clin North Am; 2015 Oct; 29(5):943-59. PubMed ID: 26461153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of haploidentical hematopoietic stem cell transplantation on 15 cases of adult-onset primary hemophagocytic lymphohistiocytosis].
    Wang YN; Wang JS; Wei N; Wu L; Jin ZL; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):511-516. PubMed ID: 32654467
    [No Abstract]   [Full Text] [Related]  

  • 14. Fludarabine/Melphalan 100 mg/m
    Park HS; Lee JH; Lee JH; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Lee KH
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1116-1121. PubMed ID: 30508593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic hematopoietic stem-cell transplantation for adult and adolescent hemophagocytic lymphohistiocytosis: a single center analysis.
    Fu L; Wang J; Wei N; Wu L; Wang Y; Huang W; Zhang J; Liu J; Wang Z
    Int J Hematol; 2016 Nov; 104(5):628-635. PubMed ID: 27431489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of different conditioning regimens on survival and engraftment for children with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoeitic stem cell transplantation: A single institution experience.
    Ali S; Wall DA; Ali M; Chiang KY; Naqvi A; Weitzman S; Gassas A; Gibson P; Brager R; Fernandez CV; Crooks B; Schechter T; Krueger J
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28477. PubMed ID: 33740322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy.
    Messina C; Zecca M; Fagioli F; Rovelli A; Giardino S; Merli P; Porta F; Aricò M; Sieni E; Basso G; Ripaldi M; Favre C; Pillon M; Marzollo A; Rabusin M; Cesaro S; Algeri M; Caniglia M; Di Bartolomeo P; Ziino O; Saglio F; Prete A; Locatelli F
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1223-1231. PubMed ID: 29410181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis.
    Cooper N; Rao K; Gilmour K; Hadad L; Adams S; Cale C; Davies G; Webb D; Veys P; Amrolia P
    Blood; 2006 Feb; 107(3):1233-6. PubMed ID: 16219800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of pediatric primary hemophagocytic lymphohistiocytosis with the HLH-94/2004 regimens and hematopoietic stem cell transplantation in China.
    Ma H; Zhang R; Zhang L; Wei A; Zhao X; Yang Y; Liu W; Li Z; Qin M; Wang T
    Ann Hematol; 2020 Oct; 99(10):2255-2263. PubMed ID: 32766934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk for complications in patients with hemophagocytic lymphohistiocytosis who undergo hematopoietic stem cell transplantation: myeloablative versus reduced-intensity conditioning regimens.
    Schechter T; Naqvi A; Weitzman S
    Expert Rev Clin Immunol; 2014 Aug; 10(8):1101-6. PubMed ID: 24871821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.